Harrow Health is trading at $40.00, down 10.9% in after-hours trading, marking a sharp reversal after several days of gains.
- The decline follows a period of fragile investor sentiment triggered by a recent Q1 2026 earnings and revenue miss.
- The stock's downward move stands out as the broader market is only modestly lower today.
- This latest drop erases recent recovery attempts as the market continues to react to the company's disappointing financial results.